GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Entero Healthcare Solutions Ltd

Entero Healthcare Solutions: Director Re-appointment Tenure Revised

MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 26 Jun 2026, 03:06 PM IST  ·  BSE ID: bb8e4165-64b4-496b-9afb-1926c271858e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board adjusted the term for two independent directors to help with future leadership changes.
🤖 AI Summary
  • Board approved revised tenure for two Non-Executive Independent Directors.
  • Mr. Rajesh Shashikant Dalal and Ms. Sandhya Gadkari Sharma re-appointed.
  • 1,475 equity shares allotted to employee under ESOP Plan 2023.
  • Decision facilitates effective succession planning and smoother board transition.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Equity Shares Allotted
1,475
Par Value per Equity Share
Rs. 10/-
🏢 How This Affects the Company
💰
Financial Impact
The allotment of 1,475 equity shares will result in a minor increase in the company's issued share capital.
⚠️
Risk Impact
Revised director tenures aim to ensure continuity and experience, potentially mitigating governance risks.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time.
👤
Who Is Affected
All shareholders are indirectly affected by changes in board composition and corporate governance.
🔍
Management Signal
Management is prioritizing structured succession planning and aligning director tenures with long-term organizational goals.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Shareholder approval for revised director re-appointment tenures.
Future board meeting outcomes on other governance matters.
Employee stock option plan utilization disclosures.
LOW RISK Routine management and board governance updates.
💡 Investor Takeaway
Entero Healthcare's board revised re-appointment tenures for two independent directors to aid succession planning and approved allotting 1,475 equity shares.
⚖️ Strengths & Concerns

✅ Positives

  • Revised director re-appointment tenure facilitates effective succession planning.
  • 1,475 equity shares allotted to eligible employee upon option exercise.
❓ Frequently Asked Questions
What was revised regarding the Non-Executive Independent Directors of Entero Healthcare Solutions?
The Board approved the revised tenure of re-appointment for Mr. Rajesh Shashikant Dalal and Ms. Sandhya Gadkari Sharma.
How many equity shares were allotted by Entero Healthcare Solutions to an employee?
The Company approved the allotment of 1,475 equity shares of Rs. 10/- each to an eligible employee.
Under which plan were the equity shares allotted by Entero Healthcare Solutions?
The equity shares were allotted upon exercise of options vested under the Entero Employee Stock Option Plan 2023.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.